Literature DB >> 27375237

Tunable Lipidoid-Telodendrimer Hybrid Nanoparticles for Intracellular Protein Delivery in Brain Tumor Treatment.

Xu Wang1, Alexa Bodman2, Changying Shi1, Dandan Guo1, Lili Wang1, Juntao Luo1, Walter A Hall2.   

Abstract

A strategy to precisely engineer lipidoid-telodendrimer binary hybrid nanoparticles that offer enhanced cell membrane permeability for therapeutic proteins to reach the intracellular targets is established. The highly controllable biochemical and physical properties of the nanoparticles make them promising for protein-based brain cancer treatment with the assistance of convection-enhanced delivery.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  glioblastoma; lipidoids; nanoparticles; protein delivery; telodendrimers

Mesh：

Substances：

Year:  2016        PMID： 27375237      PMCID： PMC4982832          DOI： 10.1002/smll.201601234

Source DB:  PubMed          Journal:  Small        ISSN： 1613-6810            Impact factor:   13.281


  49 in total

1.  Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.

Authors:  Ryuta Saito; Michal T Krauze; Charles O Noble; Daryl C Drummond; Dmitri B Kirpotin; Mitchel S Berger; John W Park; Krystof S Bankiewicz
Journal:  Neuro Oncol       Date:  2006-05-24       Impact factor: 12.300

Review 2.  Protein therapeutics: a summary and pharmacological classification.

Authors:  Benjamin Leader; Quentin J Baca; David E Golan
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

3.  Nanoscale materials for tackling brain cancer: recent progress and outlook.

Authors:  Elena A Rozhkova
Journal:  Adv Mater       Date:  2011-04-20       Impact factor: 30.849

4.  Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13.

Authors:  Edward Rustamzadeh; Daniel A Vallera; Deborah A Todhunter; Walter C Low; Angela Panoskaltsis-Mortari; Walter A Hall
Journal:  J Neurooncol       Date:  2006-05       Impact factor: 4.130

5.  Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy.

Authors:  P Duesberg; R Stindl; R Hehlmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

6.  Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours.

Authors:  E A Neuwelt; P Várallyay; A G Bagó; L L Muldoon; G Nesbit; R Nixon
Journal:  Neuropathol Appl Neurobiol       Date:  2004-10       Impact factor: 8.090

7.  Sensitivity of cancer cells to truncated diphtheria toxin.

Authors:  Yi Zhang; Wendy Schulte; Desmond Pink; Kyle Phipps; Andries Zijlstra; John D Lewis; David Morton Waisman
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

Review 8.  Convection-enhanced delivery of nanocarriers for the treatment of brain tumors.

Authors:  Emilie Allard; Catherine Passirani; Jean-Pierre Benoit
Journal:  Biomaterials       Date:  2009-01-24       Impact factor: 12.479

9.  Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development.

Authors:  Joerg U Schmohl; Deborah Todhunter; Seung Oh; Daniel A Vallera
Journal:  Toxins (Basel)       Date:  2015-10-10       Impact factor: 4.546

Review 10.  Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.

Authors:  Susana Martins; Bruno Sarmento; Domingos C Ferreira; Eliana B Souto
Journal:  Int J Nanomedicine       Date:  2007
View more
  8 in total

Review 1.  Combinatorial approaches in post-polymerization modification for rational development of therapeutic delivery systems.

Authors:  Yuanbo Zhong; Brian J Zeberl; Xu Wang; Juntao Luo
Journal:  Acta Biomater       Date:  2018-04-12       Impact factor: 8.947

2.  Zwitterionic Janus Dendrimer with distinct functional disparity for enhanced protein delivery.

Authors:  Lili Wang; Changying Shi; Xu Wang; Dandan Guo; Thomas M Duncan; Juntao Luo
Journal:  Biomaterials       Date:  2019-05-31       Impact factor: 12.479

3.  Riboflavin-containing telodendrimer nanocarriers for efficient doxorubicin delivery: High loading capacity, increased stability, and improved anticancer efficacy.

Authors:  Dandan Guo; Changying Shi; Xu Wang; Lili Wang; Shengle Zhang; Juntao Luo
Journal:  Biomaterials       Date:  2017-06-30       Impact factor: 12.479

4.  Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment.

Authors:  Lili Wang; Changying Shi; Forrest A Wright; Dandan Guo; Xu Wang; Dongliang Wang; Richard J H Wojcikiewicz; Juntao Luo
Journal:  Cancer Res       Date:  2017-04-10       Impact factor: 12.701

5.  Nanomaterials for convection-enhanced delivery of agents to treat brain tumors.

Authors:  Young-Eun Seo; Tom Bu; W Mark Saltzman
Journal:  Curr Opin Biomed Eng       Date:  2017-09-22

6.  Polycation-telodendrimer nanocomplexes for intracellular protein delivery.

Authors:  Xu Wang; Changying Shi; Lili Wang; Juntao Luo
Journal:  Colloids Surf B Biointerfaces       Date:  2017-12-12       Impact factor: 5.268

Review 7.  Telodendrimers: Promising Architectural Polymers for Drug Delivery.

Authors:  Søren Mejlsøe; Ashok Kakkar
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

8.  Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma.

Authors:  Hangxiang Wang; Liqian Zhou; Ke Xie; Jiaping Wu; Penghong Song; Haiyang Xie; Lin Zhou; Jialin Liu; Xiao Xu; Youqing Shen; Shusen Zheng
Journal:  Theranostics       Date:  2018-06-24       Impact factor: 11.556
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.